Aemetis, Inc. (NASDAQ:AMTX) Short Interest Down 17.9% in November

Aemetis, Inc. (NASDAQ:AMTX) was the recipient of a large decline in short interest during the month of November. As of November 15th, there was short interest totalling 5,540,000 shares, a decline of 17.9% from the October 31st total of 6,750,000 shares. Based on an average daily volume of 670,300 shares, the days-to-cover ratio is presently 8.3 days.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the stock. HC Wainwright reissued a “buy” rating and set a $28.00 price target on shares of Aemetis in a research note on Friday, November 15th. UBS Group cut their price target on Aemetis from $8.25 to $7.75 and set a “buy” rating on the stock in a research note on Monday, August 19th. Finally, Ascendiant Capital Markets reduced their price target on Aemetis from $20.00 to $19.00 and set a “buy” rating on the stock in a research report on Tuesday, September 3rd. One research analyst has rated the stock with a sell rating, one has given a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $12.95.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Rhumbline Advisers lifted its stake in Aemetis by 2,837.1% in the second quarter. Rhumbline Advisers now owns 52,309 shares of the specialty chemicals company’s stock valued at $157,000 after acquiring an additional 50,528 shares during the last quarter. Susquehanna Fundamental Investments LLC lifted its stake in Aemetis by 287.4% in the 2nd quarter. Susquehanna Fundamental Investments LLC now owns 126,078 shares of the specialty chemicals company’s stock valued at $379,000 after purchasing an additional 93,536 shares during the last quarter. State Board of Administration of Florida Retirement System bought a new position in Aemetis during the first quarter worth about $84,000. Bank of New York Mellon Corp acquired a new position in Aemetis during the second quarter worth approximately $306,000. Finally, Hutchinson Capital Management CA bought a new stake in Aemetis in the second quarter valued at approximately $70,000. Institutional investors and hedge funds own 27.02% of the company’s stock.

Aemetis Stock Performance

AMTX opened at $4.13 on Monday. The firm’s fifty day moving average is $3.12 and its two-hundred day moving average is $3.04. The firm has a market cap of $205.43 million, a PE ratio of -1.81 and a beta of 1.23. Aemetis has a twelve month low of $2.10 and a twelve month high of $7.03.

Aemetis (NASDAQ:AMTX) last issued its quarterly earnings data on Tuesday, November 12th. The specialty chemicals company reported ($0.38) EPS for the quarter, topping the consensus estimate of ($0.47) by $0.09. The business had revenue of $81.44 million for the quarter, compared to analyst estimates of $77.79 million. During the same period in the previous year, the business posted ($0.59) EPS. Equities analysts forecast that Aemetis will post -2.02 EPS for the current fiscal year.

About Aemetis

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.